Literature DB >> 5137574

Chemotherapy in advanced malignant diseases in Iraq.

H Talib.   

Abstract

This work discusses the experience of one surgical team in the Third Surgical Unit at the Republican Teaching Hospital, Baghdad, from 1967 to 1970. 112 patients with advanced malignant lesions in various parts of the body were dealt with. In 84, the intra-arterial route was adopted; in the remaining, systemic administration of cytotoxic agents either singly or in combination was employed. The results are reported in terms of subjective and objective response, and the various complications are discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5137574      PMCID: PMC2388039     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  10 in total

1.  CANCER CHEMOTHERAPY BY CONTINUOUS INTRA-ARTERIAL INFUSION. EXPERIENCE OF THE VETERANS ADMINISTRATION SURGICAL ADJUVANT CANCER CHEMOTHERAPY INFUSION STUDY GROUP.

Authors:  L S ROGERS
Journal:  Cancer       Date:  1964-11       Impact factor: 6.860

2.  THE TREATMENT OF HEAD AND NECK CANCER BY REGIONAL CHEMOTHERAPY.

Authors:  G WESTBURY
Journal:  Br J Plast Surg       Date:  1963-10

3.  EXTRACORPOREAL ARTERIAL PERFUSION.

Authors:  W T IRVINE
Journal:  Proc R Soc Med       Date:  1963-08

4.  THE CHALLENGE OF XERODERMA PIGMENTOSUM.

Authors:  A G MARTINS
Journal:  Br J Surg       Date:  1965-07       Impact factor: 6.939

5.  Regional chemotherapy in malignant disease.

Authors:  G WESTBURY
Journal:  Ann R Coll Surg Engl       Date:  1963-06       Impact factor: 1.891

6.  Recurrent Cancer of Head and Neck.

Authors:  G Westbury; K A Newton; J G Humble; H T Ford; D E Pegg; W F White
Journal:  Br Med J       Date:  1962-05-05

7.  Intermittent intra-arterial injection and continuous intravenous infusion in the treatment of advanced cancer.

Authors:  K A NEWTON
Journal:  Proc R Soc Med       Date:  1962-08

8.  Determinants of human tumor sensitivity to fluorinated pyrimidine chemotherapy.

Authors:  W H Wolberg
Journal:  Ann Surg       Date:  1967-10       Impact factor: 12.969

9.  Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.

Authors:  J J Costanzi; C A Coltman
Journal:  Cancer       Date:  1969-03       Impact factor: 6.860

10.  Intra-arterial cytotoxic therapy and x-ray therapy for cancer of the breast.

Authors:  P Helman; M B Bennett
Journal:  Br J Surg       Date:  1968-06       Impact factor: 6.939

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.